274
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Elevated Tear Human Neutrophil Peptides 1-3, Human Beta Defensin-2 Levels and Conjunctival Cathelicidin LL-37 Gene Expression in Ocular Rosacea

, MDORCID Icon, , MD, , MD, , MD & , PhD
Pages 1174-1183 | Received 19 Apr 2018, Accepted 23 Jul 2018, Published online: 24 Aug 2018

References

  • Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017 February;176(2):431–438. doi:10.1111/bjd.15122.
  • Gallo RL, Granstein RD, Kang S, et al. Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 2018 January;78(1):148–155. doi:10.1016/j.jaad.2017.08.037.
  • Steinhoff M, Schaub J, Leyden JJ. New insights into rosacea Pathophysiology: a review of recent findings. J Am Acad Dermatol. 2013;69(6 Suppl 1):15–26. doi:10.1016/j.jaad.2013.04.045.
  • Schwab VD, Sulk M, Seeliger S, et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):53–62.5. doi:10.1038/jidsymp.2011.6.
  • Reinholz M, Tietze JK, Kilian K, et al. Rosacea - S1 guideline. J Dtsch Dermatol Ges. 2013 August;11(8):768–80;768–79. doi:10.1111/ddg.12101.
  • Owen JA, Punt J, Stranford SA. Kuby Immunology. 7th ed. New York, NY: WH Freeman and Company; 2013.
  • Johnston RB. An overview of the innate immune system. Orange JS, Feldweg AM,eds. UpToDate.Inc. http://www.uptodate.com. Published November 07, 2017. Accessed April 01, 2018.
  • Shaw AC, Goldstein DR, Montgomery RR. Age-dependent dysregulation of innate immunity. Nat Rev Immunol. 2013 December;13(12):875–887. doi:10.1038/nri3547.
  • Rosenbaum JT, Kim HW. Innate immune signals in autoimmune and autoinflammatory uveitis. Int Rev Immunol. 2013 February;32(1):68–75. doi:10.3109/08830185.2012.750132.
  • Nussenblatt RB, Liu B, Wei L, Sen HN. The immunological basis of degenerative diseases of the eye. Int Rev Immunol. 2013 February;32(1):97–112. doi:10.3109/08830185.2012.740536.
  • Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009 April;22(2):240–273. doi:10.1128/CMR.00046-08.
  • Mohammed I, Said DG, Dua HS. Human antimicrobial peptides in ocular surface defense. Prog Retin Eye Res. 2017 November;61:1–22. doi:10.1016/j.preteyeres.2017.03.004.
  • Guaní-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, Terán LM. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol. 2010;135(1):1–11. doi:10.1016/j.clim.2009.12.004.
  • Gordon YJ, Huang LC, Romanowski EG, Yates KA, Proske RJ, McDermott AM. Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr Eye Res. 2005;30(5):385–394. doi:10.1080/02713680590934111.
  • Haynes RJ, Tighe PJ, Dua HS. Antimicrobial defensin peptides of the human ocular surface. Br J Ophthalmol. 1999;83:737–741.
  • Zhou L, Huang LQ, Beuerman RW, et al. Proteomic analysis of human tears: defensin expression after ocular surface surgery. J Proteome Res. 2004;3:410–416.
  • Hida RY, Ohashi Y, Takano Y, et al. Elevated levels of human alpha -defensin in tears of patients with allergic conjunctival disease complicated by corneal lesions: detection by SELDI ProteinChip system and quantification. Curr Eye Res. 2005;30(9):723–730. doi:10.1080/02713680591005986.
  • Lo LH, Wu PC, Wu YC, Shiea J. Characterization of human neutrophil peptides (α-Defensins) in the tears of dry eye patients. Anal. Methods. 2010;2(12):1934–1940. doi:10.1039/c0ay00243g.
  • Dua HS, Otri AM, Hopkinson A, Mohammed I. In vitro studies on the antimicrobial peptide human beta-defensin 9 (HBD9): signalling pathways and pathogen-related response (an American ophthalmological society thesis). Trans Am Ophthalmol Soc. 2014;112:50–73.
  • Narayanan S, Miller WL, McDermott AM. Expression of human beta-defensins in the conjunctival epithelium: relevance to dry eye disease. Invest Ophthalmol Vis Sci. 2003;44:3795–3801.
  • Narayanan S, Redfern RL, Miller WL, Nichols KK, McDermott AM. Dry eye disease and microbial keratitis: is there a connection? Ocul Surf. 2013;11(2):75–92. doi:10.1016/j.jtos.2012.12.002.
  • Redfern RL, Patel N, Hanlon S, et al. Toll-like receptor expression and activation in mice with experimental dry eye. Invest Ophthalmol Vis Sci. 2013;54(2):1554–1563. doi:10.1167/iovs.12-10739.
  • Abedin A, Mohammed I, Hopkinson A, Dua HS. A novel antimicrobial peptide on the ocular surface shows decreased expression in inflammation and infection. Invest Ophthalmol Vis Sci. 2008;49(1):28–33. doi:10.1167/iovs.07-0645.
  • McIntosh RS, Cade JE, Al-Abed M, et al. The spectrum of antimicrobial peptide expression at the ocular surface. Invest Ophthalmol Vis Sci. 2005 April;46(4):1379–1385. doi:10.1167/iovs.04-0607.
  • Huang LC, Petkova TD, Reins RY, Proske RJ, McDermott AM. Multifunctional roles of human cathelicidin (LL-37) at the ocular surface. Invest Ophthalmol Vis Sci. 2006;47(6):2369–2380. doi:10.1167/iovs.05-1649.
  • Yamasaki K, Gallo RL. Rosacea as a disease of cathelicidins and skin innate immunity. J Investig Dermatol Symp Proc. 2011;15(1):12–15. doi:10.1038/jidsymp.2011.4.
  • Meyer-Hoffert U, Schröder JM. Epidermal proteases in the pathogenesis of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):16–23. doi:10.1038/jidsymp.2011.2.
  • Yamasaki K, Di Nardo A, Bardan A, et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med. 2007;13(8):975–980. doi:10.1038/nm1616.
  • Kolar SS, McDermott AM. Role of host-defence peptides in eye diseases. Cell Mol Life Sci. 2011;68(13):2201–2213. doi:10.1007/s00018-011-0713-7.
  • Wilkin J, Dahl M, Detmar M, et al. National Rosacea Society Expert Committee. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004 June;50(6):907–912. doi:10.1016/j.jaad.2004.01.048.
  • Topcu-Yilmaz P, Atakan N, Bozkurt B, et al. Determination of tear and serum inflammatory cytokines in patients with rosacea using multiplex bead technology. Ocul Immunol Inflamm. 2013 October;21(5):351–359. doi:10.3109/09273948.2013.795229.
  • Gonser LI, Gonser CE, Deuter C, Heister M, Zierhut M, Schaller M. Systemic therapy of ocular and cutaneous rosacea in children. J Eur Acad Dermatol Venereol. 2017 October;31(10):1732–1738. doi:10.1111/jdv.14402.
  • Müftüoğlu IK, Akova YA. The clinical findings, follow-up and treatment results in patients with ocular rocasea. Turk J Ophthalmol. 2016;46(1):1–6. doi:10.4274/tjo.48902.
  • Irkec M, Turkish OSDI Study Group. Reliability and validity of Turkish translation of the Ocular Surface Disease Index (OSDI) in dry eye syndrome. Invest Ophthalmol Vis Sci. 2007;48:408.
  • Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017 July;15(3):539–574. doi:10.1016/j.jtos.2017.05.001.
  • Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640–650.
  • Geerling G, Tauber J, Baudouin C, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2011 March 30;52(4):2050–2064. doi:10.1167/iovs.10-6997g.
  • Ozek D, Ö EK, Artüz F. Assessment of tear functions in patients with acne rosacea without meibomian gland dysfunction. Ocul Immunol Inflamm. 2018 March 13:1–4. doi:10.1080/09273948.2018.1433305.
  • Posa A, Bräuer L, Schicht M, Garreis F, Beileke S, Paulsen F. Schirmer strip vs. capillary tube method: non-invasive methods of obtaining proteins from tear fluid. Ann Anat. 2013;195(2):137–142. doi:10.1016/j.aanat.2012.10.001.
  • Singh R, Joseph A, Umapathy T, Tint NL, Dua HS. Impression cytology of the ocular surface. Br J Ophthalmol. 2005;89:1655–1659.
  • Otri AM, Mohammed I, Al-Aqaba MA, et al. Variable expression of human Beta defensins 3 and 9 at the human ocular surface in infectious keratitis. Invest Ophthalmol Vis Sci. 2012;53(2):757–761. doi:10.1167/iovs.11-8467.
  • Schauber J, Gallo RL. Antimicrobial peptides and the skin’s immune defense system. J Allergy Clin Immunol. 2008;122(2):261–266. doi:10.1016/j.jaci.2009.07.014.
  • Park K, Elias PM, Oda Y, et al. Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway. J Biol Chem. 2011 September 30;286(39):34121–34130. doi:10.1074/jbc.M111.250431.
  • Vieira AC, Mannis MJ. Ocular rosacea: common and commonly missed. J Am Acad Dermatol. 2013;69(6 Suppl 1):S36–S41. doi:10.1016/j.jaad.2013.04.042.
  • Tjabringa GS, Aarbiou J, Ninaber DK, et al. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol. 2003 15;171(12):6690–6696.
  • Määttä M, Kari O, Tervahartiala T, et al. Tear fluid levels of MMP-8 are elevated in ocular rosacea treatment effect of oral doxycycline. Graefes Arch Clin Exp Ophthalmol. 2006;244(8):957–962. doi:10.1007/s00417-005-0212-3.
  • Pu LL, Smith PD, Payne WG, et al. Overexpression of transforming growth factor beta-2 and its receptor in rhinophyma: an alternative mechanism of pathobiology. Ann Plast Surg. 2000;45:515–519.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.